M A Cristofanilli

Affiliations

Division of Hematology and Medical Oncology, Weill Cornell Medicine, New York.

Publications (1)

Lasofoxifene versus fulvestrant for ER+/HER2- metastatic breast cancer with an ESR1 mutation: results from the randomized, phase II ELAINE 1 trial.

Annals of oncology : official journal of the European Society for Medical Oncology

Avec: M P Goetz , N A Bagegni , G Batist , A Brufsky , M A Cristofanilli , S Damodaran , B R Daniel , G F Fleming , W J Gradishar , S L Graff , M T Grosse Perdekamp , E Hamilton , S Lavasani , A Moreno-Aspitia , T O'Connor , T J Pluard , H S Rugo , S L Sammons , L S Schwartzberg , D G Stover , G A Vidal , G Wang , E Warner , R Yerushalmi , P V Plourde , D J Portman , E N Gal-Yam

Réseau de co-auteurs

M P Goetz 1 collaboration

N A Bagegni 1 collaboration

G Batist 1 collaboration

A Brufsky 1 collaboration

S Damodaran 1 collaboration

B R Daniel 1 collaboration

G F Fleming 1 collaboration

W J Gradishar 1 collaboration

S L Graff 1 collaboration

M T Grosse Perdekamp 1 collaboration

E Hamilton 1 collaboration

S Lavasani 1 collaboration

A Moreno-Aspitia 1 collaboration

T O'Connor 1 collaboration

T J Pluard 1 collaboration

H S Rugo 1 collaboration

S L Sammons 1 collaboration

L S Schwartzberg 1 collaboration

D G Stover 1 collaboration

G A Vidal 1 collaboration

G Wang 1 collaboration

E Warner 1 collaboration

R Yerushalmi 1 collaboration

P V Plourde 1 collaboration

D J Portman 1 collaboration

E N Gal-Yam 1 collaboration